Jun 24 |
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
|
Jun 13 |
Contineum: LPA1R Antagonist Drug Advancement Against IPF With Proven Track Model
|
Jun 4 |
Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference
|
Jun 3 |
Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary
|
May 20 |
Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
|
May 16 |
Contineum Therapeutics GAAP EPS of -$3.55
|
May 16 |
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
|
Apr 30 |
Stifel, Morgan Stanley bullish on newly public Contineum
|
Apr 16 |
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
|
Apr 5 |
Contineum Therapeutics stock slides 10% following $110M IPO
|